Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting

Neuropsychopharmacology

Volumn 31, Issue 2, 2006, Pages 297-309

  Floresco, Stan B ^a   Magyar, Orsolya ^a   Ghods Sharifi, Sarvin ^a   Vexelman, Claudia ^a   Tse, Marie T L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ADHD; D4 receptor; Dopamine; Frontal lobe; Rat; Schizophrenia

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; PD 168 077; QUINPIROLE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSOCIATION; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; MAZE TEST; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CUES; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MAZE LEARNING; MICROINJECTIONS; PHOTIC STIMULATION; PREFRONTAL CORTEX; PROBLEM SOLVING; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE;

EID: 30944469609     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300825     Document Type: Article

References (79)

1. Ariano MA, Wang J, Noblett KL, Larso ER, Sibley DR (1997). Cellular distribution of the rat D4 receptor protein in the CNS using anti-receptor antisera. Brain Res 752: 26-34.
2. Arnsten AF, Murphy B, Merchant K (2000). The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology 23: 405-410.
3. Baddeley AD (1998). Recent developments in working memory. Curr Opin Neurobiol 8: 234-238.
4. Beyer CE, Steketee JD (2000). Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat. Psychopharmaacology 151: 211-218.
5. Birrell JM, Brown VJ (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320-4324.
6. Broderick PA, Piercey MF (1998). Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. J Neural Transm 105: 749-767.
7. Brozowski TS, Brown RM, Rosvold HE, Goldman PS (1979). Cognitive deficits caused by regional depletion of dopamine in prefrontal cortex of Rhesus monkey. Science 205: 929-932.
8. Chen L, Yang CR (2002). Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol 87: 2324-2336.
9. Chen NN, Pan WH (2000). Regulatory effects of D2 receptors in the ventral tegmental area on the mesocorticolimbic dopaminergic pathway. J Neurochem 74: 2576-2582.
10. Chudasama Y, Bussey TJ, Muir JL (2001). Effects of selective thalamic and prelimbic cortex lesions on two types of visual discrimination and reversal learning. Eur J Neurosci 14: 1009-1020.
11. Chudasama Y, Robbins TW (2004). Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology 29: 1628-1636.
12. Crofts HS, Dalley JW, Collins P, Van Denderen JCM, Everitt BJ, Robbins TW et al (2001). Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire attentional set. Cerebral Cortex 11: 1015-1026.
13. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S et al (1991). The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11: 1907-1917.
14. Dias R, Aggleton JP (2000). Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioral flexibility. Eur J Neurosci 12: 4457-4466.
15. Dias R, Robbins TW, Roberts AC (1997). Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from 'on-line' processing. J Neurosci 17: 9285-9297.
16. Druzin MY, Kurzina NP, Malinina EP, Kozlov AP (2000). The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task. Behav Brain Res 109: 99-111.
17. Durcan MJ, Rigdon GC, Norman MH, Morgan PF (1995). Is clozapine selective for the dopamine D4 receptor? Life Sci 57: PL275-PL283.
18. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
19. Floresco SB, Phillips AG (2001). Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex. Behav Neurosci 115: 934-939.
20. Friedman JI, Temporini H, Davis KL (1999). Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 45: 1-16.
21. Fujii DE, Ahmed I, Jokumsen M, Compton JM (1997). The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. J Neuropsychiatry Clin Neurosci 9: 240-245.
22. Fuster JM (2000). Executive frontal functions. Exp Brain Res 133: 66-70.
23. Glase SA, Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ et al (1997). Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists. J Med Chem 40: 1771-1772.
24. Goldman-Rakic PS (1995). Cellular basis of working memory. Neuron 14: 477-485.
25. Harvey PD, Green MF, McGurk SR, Meltzer HY (2003). Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology 169: 404-411.
26. Hatcher PD, Brown VJ, Tait DS, Bate S, Overend P, Hagan JJ et al (2005). 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology, April 21 [Epub ahead of print].
27. Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE et al (2001). Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. Bioorg Med Chem Lett 11: 1375-1377.
28. Jardemark K, Marcus MM, Konradsson A, Svensson TH (2004). The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex. Int J Neuropsychopharmacol 7: 1-6.
29. Jentsch JD, Taylor JR, Redmond Jr DE, Elsworth JD, Youngren KD, Roth RH (1999). Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology 142: 78-84.
30. Kawashima N, Okuyama S, Omura T, Chaki S, Tomisawa K (1999). Effects of selective dopamine D4 receptor blockers, NRAO160 and L-745,870, on A9 and A10 dopamine neurons in rats. Life Sci 65: 2561-2571.
31. Kohler C, Hall H, Gawell L (1986). Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors. Eur J Pharmacol 120: 217-226.
32. Kramer MS, Last B, Getson A, Reines SA (1997). The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. Arch Gen Psychiatry 54: 567-572.
33. Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA. (2004). 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51: 158-164.
34. Lebron K, Milad MR, Quirk GJ (2004). Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem 11: 544-548.
35. McFarland K, Kalivas PW (2001). The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21: 8655-8663.
36. Mehta MA, Manes FF, Magnolfi G, Sahakian BJ, Robbins TW (2004). Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology 176: 331-342.
37. Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V et al (1998). S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]-dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. J Pharmacol Exp Ther 287: 167-186.
38. Morrow BA, Elsworth JD, Rasmusson AM, Roth RH (1999). The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92: 553-564.
39. Mrzijak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS (1996). Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381: 245-248.
40. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH (1996). Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93: 1325-1329.
41. Pantelis C, Barber FZ, Barnes TR, Nelson HE, Owen AM, Robbins TW (1999). Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37: 251-270.
42. Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M et al (1997). Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283: 636-647.
43. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press: San Diego.
44. Phillips AG, Ahn S, Floresco SB (2004). Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 24: 547-553.
45. Ragozzino ME (2002). The effects of dopamine D1 receptor blockade on the prelimbic-infralimbic areas on behavioral flexibility. Learn Mem 9: 18-28.
46. Ragozzino ME, Ragozzino KE, Mizumori SJ, Kesner RP (2002). Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behav Neurosci 116: 105-115.
47. Ragozzino ME, Detrich S, Kesner RP (1999). Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J Neurosci 19: 4585-4594.
48. Reeve WV, Schandler SL (2001). Frontal lobe functioning in adolescents with attention deficit hyperactivity disorder. Adolescence 36: 749-765.
49. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ et al (1994). 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 14: 2531-2544.
50. Romanides AJ, Duffy P, Kalivas PW (1999). Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 92: 97-106.
51. Sawaguchi T (2001). The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task. Neurosci Res 41: 115-128.
52. Sawaguchi T, Matsumura M, Kubota K (1990). Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 63: 1385-1400.
53. Seamans JK, Durstewitz D, Christie B, Stevens CF, Sejnowski TJ (2001a). Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 98: 301-306.
54. 1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18: 1613-1621.
55. Seamans JK, Gorelova N, Durstewitz D, Yang CR (2001b). Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21: 3628-3638.
56. Seamans JK, Yang CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-58.
57. Seeman P, Guan HC, Van Tol HH (1993). Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445.
58. Seeman P, Ulpian C (1988). Dopamine D1 and D2 receptor selectivities of agonists and antagonists. Adv Exp Med Biol 235: 55-63.
59. Sesack SR, King SW, Bressler CN, Watson SJ, Lewis DA (1995). Electron microscopic visualization of dopamine D2 receptors in the forebrain: cellular, regional, and species comparisons. Soc Neurosci Abstr 21: 365.
60. Shah AA, Sjovold T, Treit D (2004). Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats. Eur J Neurosci 19: 3393-3397.
61. Slamecka NJ (1968). A methodological analysis of shift paradigms in human discrimination learning. Psychol Bull 69: 423-438.
62. Stefani MR, Groth K, Moghaddam B (2003). Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci 117: 728-737.
63. Sun W, Rebec GV (2005). The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology 177: 315-323.
64. Svingos AL, Periasamy S, Pickel VM (2000). Presynaptic dopamine D(4) receptor localization in the rat nucleus accumbens shell. Synapse 36: 222-232.
65. Tarazi FI, Zhang K, Baldessarini RJ (2004). Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res 24: 131-147.
66. Trantham-Davidson H, Neely LC, Lavin A, Seamans JK (2004). Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24: 10652-10659.
67. Tseng KY, O'Donnell P (2004). Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24: 5131-5139.
68. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ (2004). Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24: 5331-5335.
69. Vincent SL, Khan Y, Benes FM (1993). Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J Neurosci 13: 2551-2564.
70. Wang X, Zhong P, Gu Z, Yan Z (2003). Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci 23: 9852-9861.
71. Wang X, Zhong P, Yan Z (2002). Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 22: 9185-9193.
72. Wedzony K, Chocyk A, Mackowiak M, Fijal K, Czyrak A (2000). Cortical localization of dopamine D4 receptors in the rat brain - immunocytochemical study. J Physiol Pharmacol 51: 205-221.
73. Williams GV, Goldman-Rakic PS (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-575.
74. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 23: 1-16.
75. Woodward RM, Panicker MM, Miledi R. (1992). Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes. Proc Natl Acad Sci USA 89: 4708-4712.
76. Yang P, Chung LC, Chen CS, Chen CC (2004). Rapid improvement in academic grades following methylphenidate treatment in attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 58: 37-41.
77. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535.
78. Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ (2004). Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 29: 1648-1655.
79. Zheng P, Zhang XX, Bunney BS, Shi WX (1999). Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91: 527-535.